Screening Options for Preventing Cervical Cancer

Sarah Feldman^{1

2}

Affiliations

¹ Division of Gynecologic Oncology, Brigham and Women's Hospital, Boston, Massachusetts.
² Department of Obstetrics, Gynecology and Reproductive Biology, Harvard Medical School, Boston, Massachusetts.

Comment

Sarah Feldman. JAMA Intern Med. 2019.

. 2019 Jul 1;179(7):879-880.

doi: 10.1001/jamainternmed.2019.0298.

Sarah Feldman^{1

2}

¹ Division of Gynecologic Oncology, Brigham and Women's Hospital, Boston, Massachusetts.
² Department of Obstetrics, Gynecology and Reproductive Biology, Harvard Medical School, Boston, Massachusetts.

No abstract available

Comment on

Estimated Quality of Life and Economic Outcomes Associated With 12 Cervical Cancer Screening Strategies: A Cost-effectiveness Analysis.
Sawaya GF, Sanstead E, Alarid-Escudero F, Smith-McCune K, Gregorich SE, Silverberg MJ, Leyden W, Huchko MJ, Kuppermann M, Kulasingam S. Sawaya GF, et al. JAMA Intern Med. 2019 Jul 1;179(7):867-878. doi: 10.1001/jamainternmed.2019.0299. JAMA Intern Med. 2019. PMID: 31081851 Free PMC article.
Clinical Evaluation of Human Papillomavirus Screening With p16/Ki-67 Dual Stain Triage in a Large Organized Cervical Cancer Screening Program.
Wentzensen N, Clarke MA, Bremer R, Poitras N, Tokugawa D, Goldhoff PE, Castle PE, Schiffman M, Kingery JD, Grewal KK, Locke A, Kinney W, Lorey TS. Wentzensen N, et al. JAMA Intern Med. 2019 Jul 1;179(7):881-888. doi: 10.1001/jamainternmed.2019.0306. JAMA Intern Med. 2019. PMID: 31081870 Free PMC article.